Tango Therapeutics Inc (TNGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -101,594 | -62,845 | -78,729 | -39,876 | -130,302 |
| Depreciation Amortization | -407 | -118 | -113 | -16 | -2,118 |
| Accounts payable and accrued liabilities | -825 | 406 | 750 | 1,630 | -1,184 |
| Other Working Capital | -67,199 | -69,600 | -15,172 | -10,016 | -31,746 |
| Other Operating Activity | 31,139 | 22,989 | 15,048 | 6,581 | 33,849 |
| Operating Cash Flow | $-138,886 | $-109,168 | $-78,216 | $-41,697 | $-131,501 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,048 | -826 | -675 | -51 | -754 |
| Purchase Of Investment | -264,457 | -89,437 | -71,100 | -47,164 | -240,888 |
| Sale Of Investment | 224,640 | 185,115 | 119,150 | 77,812 | 327,768 |
| Investing Cash Flow | $-40,865 | $94,852 | $47,375 | $30,597 | $86,126 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 222,536 | 3,124 | 583 | 2 | 47,664 |
| Other Financing Activity | -36 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $222,500 | $3,124 | $583 | $2 | $47,664 |
| Beginning Cash Position | 72,097 | 72,097 | 72,097 | 72,097 | 69,808 |
| End Cash Position | 114,846 | 60,905 | 41,839 | 60,999 | 72,097 |
| Net Cash Flow | $42,749 | $-11,192 | $-30,258 | $-11,098 | $2,289 |
| Free Cash Flow | |||||
| Operating Cash Flow | -138,886 | -109,168 | -78,216 | -41,697 | -131,501 |
| Capital Expenditure | -1,048 | -826 | -675 | -51 | -754 |
| Free Cash Flow | -139,934 | -109,994 | -78,891 | -41,748 | -132,255 |